176 related articles for article (PubMed ID: 23685887)
1. New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides.
Inamdar GS; Pandya AN; Thakar HM; Sudarsanam V; Kachler S; Sabbadin D; Moro S; Klotz KN; Vasu KK
Eur J Med Chem; 2013 May; 63():924-34. PubMed ID: 23685887
[TBL] [Abstract][Full Text] [Related]
2. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
[TBL] [Abstract][Full Text] [Related]
3. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
[TBL] [Abstract][Full Text] [Related]
4. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP
J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637
[TBL] [Abstract][Full Text] [Related]
5. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
Cheong SL; Dolzhenko A; Kachler S; Paoletta S; Federico S; Cacciari B; Dolzhenko A; Klotz KN; Moro S; Spalluto G; Pastorin G
J Med Chem; 2010 Apr; 53(8):3361-75. PubMed ID: 20307065
[TBL] [Abstract][Full Text] [Related]
6. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and SAR studies of analogues of 4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-N-thiazol-2-yl-benzamide (Lu AA41063) as adenosine A2A receptor ligands with improved aqueous solubility.
Mikkelsen GK; Langgård M; Schrøder TJ; Kreilgaard M; Jørgensen EB; Brandt G; Griffon Y; Boffey R; Bang-Andersen B
Bioorg Med Chem Lett; 2015 Mar; 25(6):1212-6. PubMed ID: 25701253
[TBL] [Abstract][Full Text] [Related]
8. Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data.
van Westen GJ; van den Hoven OO; van der Pijl R; Mulder-Krieger T; de Vries H; Wegner JK; Ijzerman AP; van Vlijmen HW; Bender A
J Med Chem; 2012 Aug; 55(16):7010-20. PubMed ID: 22827545
[TBL] [Abstract][Full Text] [Related]
9. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
10. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA
J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859
[TBL] [Abstract][Full Text] [Related]
11. Novel thiazole-thiophene conjugates as adenosine receptor antagonists: synthesis, biological evaluation and docking studies.
Pandya DH; Sharma JA; Jalani HB; Pandya AN; Sudarsanam V; Kachler S; Klotz KN; Vasu KK
Bioorg Med Chem Lett; 2015 Mar; 25(6):1306-9. PubMed ID: 25686851
[TBL] [Abstract][Full Text] [Related]
12. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes.
Volpini R; Camaioni E; Costanzi S; Vittori S; Klotz KN; Cristalli G
Nucleosides Nucleotides; 1999; 18(11-12):2511-20. PubMed ID: 10639752
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists.
Mishra CB; Sharma D; Prakash A; Kumari N; Kumar N; Luthra PM
Bioorg Med Chem; 2013 Oct; 21(19):6077-83. PubMed ID: 23953686
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of metabolites of 2-n-butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), a potent antagonist of the A2A adenosine receptor for the treatment of Parkinson's disease.
Piersanti G; Bartoccini F; Lucarini S; Cabri W; Stasi MA; Riccioni T; Borsini F; Tarzia G; Minetti P
J Med Chem; 2013 Jul; 56(13):5456-63. PubMed ID: 23789814
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
18. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
[TBL] [Abstract][Full Text] [Related]
19. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.
Cappellacci L; Franchetti P; Pasqualini M; Petrelli R; Vita P; Lavecchia A; Novellino E; Costa B; Martini C; Klotz KN; Grifantini M
J Med Chem; 2005 Mar; 48(5):1550-62. PubMed ID: 15743197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]